中新网上海11月14日电(范宇斌 郭琪 任晓慧 殷志敏)近日，20家民盟盟员企业聚焦智能制造、生物医药 等先导产业开展专场招聘，众多高质量岗位吸引应聘者驻足咨询。这场民盟企业家"走进徐汇"暨2025年 秋季招聘活动，是民盟上海市委会与中共徐汇区委携手推进高质量充分就业的生动实践。 就业是最大的民生。"促进高质量充分就业"既是中共二十届四中全会关于民生保障的重要内容，也 是"十五五"规划的主要目标之一。为贯彻落实全会精神及"两个融入"工作要求，民盟上海市委会与中共 徐汇区委共同指导开展此次系列招聘活动。除本场活动外，后续还将在中智大厦、漕河泾万科就业集市 等场所持续举办招聘活动，推动就业服务从"阶段性"升级为"常态化"长效机制。 徐汇区承载上海"百年记忆"，铭刻着民盟的光辉历程，大批盟员曾为区域发展贡献力量。此次民盟企业 家"走进徐汇"，不仅带来20家企业的100个高质量岗位、300多个就业机会，后续还将有80位民盟企业家 陆续入驻，提供近千个就业机会。活动前期发布岗位信息后，求职者报名踊跃，部分岗位已完成精准匹 配和意向面试，现场6位民盟企业家代表与12位应聘者正式签约。 上海民盟企业家"走进徐汇"搭平台 精 ...

天眼查App显示，近日，苏州三澳鑫材料科技有限公司成立，法定代表人为高为民，注册资本50万人民 币，经营范围为一般项目：技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；新材料 技术研发；资源再生利用技术研发；塑料制品销售；塑料制品制造；合成材料销售；工程塑料及合成树 脂销售；玻璃纤维增强塑料制品制造；玻璃纤维增强塑料制品销售；化工产品销售（不含许可类化工产 品）；模具销售；模具制造；金属材料销售；金属制品研发；金属制品销售；金属结构制造（除依法须 经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

天眼查App显示，近日，广州立可涂科技有限公司成立，注册资本3万人民币，经营范围为消防技术服 务;工程技术服务（规划管理、勘察、设计、监理除外）;耐火材料生产;耐火材料销售;建筑材料销售;新 型建筑材料制造（不含危险化学品）;工程塑料及合成树脂销售;消防器材销售;隔热和隔音材料销售;隔 热和隔音材料制造;对外承包工程;合成材料制造（不含危险化学品）;合成材料销售;涂料制造（不含危 险化学品）;食品销售（仅销售预包装食品）;食品互联网销售（仅销售预包装食品）;互联网销售（除销 售需要许可的商品）;涂料销售（不含危险化学品）;新材料技术研发;农业科学研究和试验发展;自然科 学研究和试验发展。 ...

天眼查App显示，近日，东莞共聚材料科技有限公司成立，注册资本100万人民币，经营范围为一般项 目：生态环境材料制造；生态环境材料销售；新材料技术研发；新材料技术推广服务；合成材料制造 （不含危险化学品）；工程塑料及合成树脂销售；合成材料销售；新型膜材料销售；新型膜材料制造； 照明器具制造；照明器具销售；塑料制品制造；塑料制品销售；机械设备销售；机械设备研发；电子产 品销售；新型建筑材料制造（不含危险化学品）；针纺织品及原料销售；针纺织品销售；皮革制品销 售；皮革制品制造；化妆品零售；金属制品销售；金属制品研发；金属链条及其他金属制品制造；广播 影视设备销售；仪器仪表销售；水上运输设备销售；管道运输设备销售；铁路运输设备销售；货物进出 口。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Core Insights - Chengdu Xincai Material Technology Co., Ltd. has been established with a registered capital of 1 million RMB [1] - The company is engaged in various business activities including technology services, sales of synthetic materials, chemical products, hardware, office supplies, and construction materials [1] Company Overview - The legal representative of the company is Gou Ying [1] - The registered capital is 1 million RMB, indicating a relatively small scale of initial investment [1] Business Scope - The company’s business scope includes technology services, development, consulting, and transfer [1] - It also involves sales of synthetic materials, chemical products (excluding licensed chemical products), hardware products, office supplies, and daily necessities [1] - Additionally, the company is involved in landscaping engineering, electrical wire and cable operations, rubber products sales, labor protection supplies, and construction waterproofing materials [1]

Core Points - Kema Technology announced on October 30 that it received a notification from the Shenzhen Stock Exchange regarding the acceptance of its application for issuing convertible bonds to unspecified objects [2] - The application documents submitted by the company were deemed complete by the Shenzhen Stock Exchange, which decided to accept the application [2] - The issuance of convertible bonds is subject to further review by the Shenzhen Stock Exchange and requires approval from the China Securities Regulatory Commission, introducing uncertainty regarding the final approval and timeline [2]

Core Points - Company received notification from Shenzhen Stock Exchange regarding the acceptance of its application for issuing convertible bonds to unspecified objects [1] - The application documents submitted by the company were found to be complete and have been accepted for review by the exchange [1] - The issuance of convertible bonds is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission [1]

Core Viewpoint - The listing of three unprofitable companies on the Sci-Tech Innovation Board marks a significant step in providing a platform for high-quality unprofitable tech enterprises, enhancing their predictability in going public [1] Group 1: Listing and Market Response - Three unprofitable companies, Wuhan Heyuan Biotechnology Co., Ltd., Xi'an Yiswei Material Technology Co., Ltd., and Guangzhou Bibete Pharmaceutical Co., Ltd., have officially listed on the Sci-Tech Innovation Board, increasing the total number of companies on the board to 592 [1] - The Shanghai Stock Exchange's revised rules in March allow unprofitable companies to adopt differentiated lock-up periods, encouraging institutional investors to play a larger role in new stock pricing [2] - The enthusiasm of institutional investors is reflected in the high subscription rates for the differentiated lock-up tiers, with A1 and A2 tiers accounting for over 70% of the total subscription volume for Heyuan Biotechnology [2][3] Group 2: Company Perspectives - Xi'an Yiswei's chairman emphasized that the initial losses are part of a necessary process for technological breakthroughs and that the listing is a milestone for the company, enabling it to enhance its core competitiveness [4] - Heyuan Biotechnology's chairman stated that the listing on the Sci-Tech Innovation Board is crucial for accelerating the company's industrialization process and improving its competitive capabilities [5] Group 3: Capital Market Dynamics - The establishment of the Sci-Tech Innovation Board's growth tier is expected to attract more patient capital into the technology sector, enhancing the confidence of tech companies and stimulating investment enthusiasm in the venture capital industry [6] - The new policies are set to inject vitality into the index system, providing a solid foundation for developing targeted indices focused on unprofitable high-R&D enterprises [6] - The improved market structure and transparency are anticipated to create a better investment environment for long-term and patient capital, promoting a virtuous cycle between technology, industry, and capital [6]

Core Insights - Three unprofitable companies, Wuhan Heyuan Biotechnology Co., Ltd., Xi'an Yiswei Material Technology Co., Ltd., and Guangzhou Bibete Pharmaceutical Co., Ltd., have officially listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, marking a significant milestone for the board's growth layer [1] Company Perspectives - Heyuan Biotechnology emphasizes the importance of long-term capital and patient investors, stating that their listing accelerates industrialization and enhances competitive capabilities in the biopharmaceutical sector [2] - Xi'an Yiswei highlights the role of recent policy reforms in facilitating access to capital markets, allowing for accelerated technology transformation and improved industrialization capabilities [3] - Both companies express a commitment to continuous technological innovation and adherence to regulatory requirements, aiming to enhance product quality and management efficiency [4] Sponsor Institution Insights - The sponsor institution, Guotai Junan, underscores the significance of the Sci-Tech Innovation Board's growth layer for both companies and the industry, noting the high R&D investment and associated risks, but also the substantial benefits upon successful product development [5] - The board is designed to support high-tech companies with tailored listing standards and regulatory logic, reflecting a commitment to fostering high-quality economic development [6] Investor Perspectives - Investment institutions involved with the newly listed companies express that the Sci-Tech Innovation Board's policies have broadened exit channels and improved investment precision, thereby enhancing capital circulation efficiency [7] - The reforms are seen as a solution to the financing challenges faced by unprofitable tech companies, allowing for a positive cycle of technological breakthroughs and capital reinvestment [8]

Group 1 - A new company, Changzhou Jirui Material Technology Co., Ltd., has been established with a registered capital of 1 million RMB [1] - The legal representative of the company is Fu Bingjie [1] - The company's business scope includes a wide range of services and products, such as new material technology promotion, coating processing, chemical product sales, and various material sales [1] Group 2 - The company is involved in the sales of high-performance sealing materials, packaging materials, and electronic products, among others [1] - It also offers technical services, development, consulting, and management services related to production lines [1] - The company operates under the principle of conducting business activities independently with its business license, except for projects that require approval [1]